Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations

doi:10.3748/wjg.v21.i36.10274

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 36

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10216)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

898

WORD

270

HTML

6539

Tables (1-5)

187

Sum=7894

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

886

Download

1436

Sum=2322

Sep 28, 2015 (publication date) through Jul 2, 2024

Times Cited of This Article

Times Cited (74)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 28, 2015; 21(36): 10274-10289
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10274

Table 1 Definition of resolved hepatitis B virus infection, inactive carrier state, chronic hepatitis B, and immunization due to vaccination

	HBsAg	Anti-HBs	HBeAg	Anti-HBe	Anti-HBc	ALT	HBV-DNA in serum (copies/mL)	HBV-DNA in the liver	Liver injury
Resolved infection	-	+/-	-	+/-	+/-	Normal	Negative	+	No
Inactive carriers	+	-	-	+	+	Normal	Negative to 10⁴	+	No
Chronic hepatitis B	+	-	+	-	+	Elevated	> 10⁵	+	Yes
(HBeAg-positive)	+	-	+	-	+	Elevated	> 10⁵	+	Yes
Chronic hepatitis B	+	-	-	+	+	Elevated	> 10⁴	+	Yes
(HBeAg-negative)	+	-	-	+	+	Elevated	> 10⁴	+	Yes
Immunized	-	+	-	-	-	Normal	Negative	-	No

HBV: Hepatitis B virus; HBsAg: Hepatitis B surface antigen; anti-HBs: Anti-hepatitis B surface antibody; HBeAg: Hepatitis B e antigen; anti-HBe: Anti-hepatitis B e antibody; anti-HBc: Anti-hepatitis B core antibody; ALT: Alanine aminotransferase.

Citation: Mori S, Fujiyama S. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World J Gastroenterol 2015; 21(36): 10274-10289
URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10274.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10274